Expanding the existing Health Care plant in India
To accelerate organic growth, Datwyler is continuously expanding and updating its existing sites, investing CHF 70 million in expanding the existing Health Care plant in India belonging to the Sealing Solutions division over the next two years, for example. This will expand production capacity there by around 50% from 2020 and provide additional buildings reserves – a necessary step if foreseeable capacity bottlenecks are to be prevented from 2020 onwards. Together with the new plant at its site in Delaware, USA, being brought into operation in late 2018, Datwyler is well positioned to benefit from the rapidly growing demand for high-quality components for prefilled syringes and other modern drug delivery systems.
Modernising ERP software
To accelerate the digital transformation, Datwyler is updating and expanding its ERP software package, with the Group investing some CHF 50 million over the next years. With these measures, Datwyler is increasing the efficiency of its business processes, improving data quality, increasing IT security and laying strong yet flexible foundations for future digital applications. This will also allow future acquisitions to be integrated more quickly and easily.